Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 10, 2010
[Analysis of high-risk multiple myeloma patients treated with high-dose chemotherapy]Shingo Kurahashi, Kotaro Suzuki, Akiyo Sawamoto, et al.
Internal Medicine (Tokyo, Japan)|November 5, 2025
Multiple Elective Surgeries and Cord Blood Transplantation for Multi-refractory Monomorphic Epitheliotropic Intestinal T-cell LymphomaMiki Watanabe, Yu Nakashima, Yurika Yamada, et al.
Palliative Medicine Reports|March 24, 2023
End-of-Life Care of Acute Myeloid Leukemia Compared with Aggressive lymphoma in Patients Who Are Eligible for Intensive Chemotherapy: An Observational Study in a Japanese Community HospitalMasato Kokaji, Naoto Imoto, Miki Watanabe, et al.
British Journal of Haematology|December 5, 2022
Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo-controlled, double-blind, parallel-group studyMasataka Kuwana, Tomoki Ito, Shugo Kowata, et al.
International Journal of Hematology|January 4, 2022
Lymphoma during pregnancy in Japan: a multicenter retrospective cohort studyChie Onishi, Momoko Nishikori, Kimikazu Yakushijin, et al.
Transplantation and Cellular Therapy|April 10, 2021
Comparison of Transplantation Outcomes after Foscarnet and Ganciclovir Administration as First-Line Anti-Cytomegalovirus Preemptive TherapyKotaro Miyao, Seitaro Terakura, Yukiyasu Ozawa, et al.
Cancer Science|November 7, 2022
Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP-IGH fusion geneKoya Odaira, Takahiko Yasuda, Kentaro Okada, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 14, 2018
Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell TransplantationHiroyuki Takamatsu, Takeshi Yamashita, Shingo Kurahashi, et al.
International Journal of Hematology|January 17, 2025
Post-transplant TKIs for Ph+ ALL: practices to date and clinical significanceSatoshi Nishiwaki, Seitaro Terakura, Takanobu Morishita, et al.
International Journal of Hematology|February 17, 2025
Zanubrutinib in Japanese treatment-naive and relapsed/refractory patients with Waldenström macroglobulinemia and CLL/SLLKoji Izutsu, Takayuki Ishikawa, Kazuyuki Shimada, et al.
Pageof 6